Search research articles
Contact Us
Filters
Showing results (51-60 of 154) with videos related to
Page
of 16
Sort By:
Lab on a Chip
|
March 7, 2025
A gut-brain axis on-a-chip platform for drug testing challenged with donepezil
Francesca Fanizza, Simone Perottoni, Lucia Boeri, et al.
Lab on a Chip
|
March 20, 2026
Correction: A gut-brain axis on-a-chip platform for drug testing challenged with donepezil
Francesca Fanizza, Simone Perottoni, Lucia Boeri, et al.
Current Alzheimer Research
|
November 2, 2018
Asymptomatic Carriers of Presenilin-1 E318G Variant Show no Cerebrospinal Fluid Biochemical Signs Suggestive of Alzheimer's disease in a Family with Late-onset Dementia
Vladimiro Artuso, Luisa Benussi, Roberta Ghidoni, et al.
Biomedicines
|
July 27, 2024
Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 <i>Drosophila</i> Models
Hoai Nam Nguyen, Grazia Galleri, Antonio Rassu, et al.
Thescientificworldjournal
|
January 25, 2014
Hydrogel-based nanocomposites and mesenchymal stem cells: a promising synergistic strategy for neurodegenerative disorders therapy
Diego Albani, Antonio Gloria, Carmen Giordano, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 28, 2018
Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder
Filippo Corponi, Stefano Bonassi, Eduard Vieta, et al.
Journal of Molecular Neuroscience : MN
|
December 21, 2017
Hot Genes in Schizophrenia: How Clinical Datasets Could Help to Refine their Role
Stefano Porcelli, Soo-Jung Lee, Changsu Han, et al.
Neurobiology of Disease
|
December 19, 2006
The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level
Marzia Pesaresi, Sara Batelli, Francesca Prato, et al.
International Journal of Alzheimer'S Disease
|
June 11, 2011
A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk
Letizia Polito, Francesca Prato, Serena Rodilossi, et al.
Bioengineering & Translational Medicine
|
May 23, 2022
The microbiota-gut-brain axis and epilepsy from a multidisciplinary perspective: Clinical evidence and technological solutions for improvement of in vitro preclinical models
Federica Fusco, Simone Perottoni, Carmen Giordano, et al.
Page
of 16
Search research articles
Search
Showing results (51-60 of 154) with videos related to
Sort By:
Page
of 16
Lab on a Chip
|
March 7, 2025
A gut-brain axis on-a-chip platform for drug testing challenged with donepezil
Francesca Fanizza, Simone Perottoni, Lucia Boeri, et al.
Lab on a Chip
|
March 20, 2026
Correction: A gut-brain axis on-a-chip platform for drug testing challenged with donepezil
Francesca Fanizza, Simone Perottoni, Lucia Boeri, et al.
Current Alzheimer Research
|
November 2, 2018
Asymptomatic Carriers of Presenilin-1 E318G Variant Show no Cerebrospinal Fluid Biochemical Signs Suggestive of Alzheimer's disease in a Family with Late-onset Dementia
Vladimiro Artuso, Luisa Benussi, Roberta Ghidoni, et al.
Biomedicines
|
July 27, 2024
Evaluation of Neuroinflammatory Contribution to Neurodegeneration in LRRK2 <i>Drosophila</i> Models
Hoai Nam Nguyen, Grazia Galleri, Antonio Rassu, et al.
Thescientificworldjournal
|
January 25, 2014
Hydrogel-based nanocomposites and mesenchymal stem cells: a promising synergistic strategy for neurodegenerative disorders therapy
Diego Albani, Antonio Gloria, Carmen Giordano, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
August 28, 2018
Genetic basis of psychopathological dimensions shared between schizophrenia and bipolar disorder
Filippo Corponi, Stefano Bonassi, Eduard Vieta, et al.
Journal of Molecular Neuroscience : MN
|
December 21, 2017
Hot Genes in Schizophrenia: How Clinical Datasets Could Help to Refine their Role
Stefano Porcelli, Soo-Jung Lee, Changsu Han, et al.
Neurobiology of Disease
|
December 19, 2006
The urokinase-type plasminogen activator polymorphism PLAU_1 is a risk factor for APOE-epsilon4 non-carriers in the Italian Alzheimer's disease population and does not affect the plasma Abeta(1-42) level
Marzia Pesaresi, Sara Batelli, Francesca Prato, et al.
International Journal of Alzheimer'S Disease
|
June 11, 2011
A novel study and meta-analysis of the genetic variation of the serotonin transporter promoter in the italian population do not support a large effect on Alzheimer's disease risk
Letizia Polito, Francesca Prato, Serena Rodilossi, et al.
Bioengineering & Translational Medicine
|
May 23, 2022
The microbiota-gut-brain axis and epilepsy from a multidisciplinary perspective: Clinical evidence and technological solutions for improvement of in vitro preclinical models
Federica Fusco, Simone Perottoni, Carmen Giordano, et al.
Page
of 16